Latest disclosed round
Series C
- Date
- 2026-03-01
- Amount
- USD 105m
- Sector
- Biotech & techbio
- Companies House
- 10271134
Later stage / growth
Tropic Biosciences
Synthetic biology / gene editing (agri-biotech)
CandidateSeries CNorwich
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
12 linked investors
Funding record
1 disclosed round
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2026-03-01 | Series C | $105M / €91.3M | Forbion (Bioeconomy Fund), Corteva (Corteva Catalyst), Just Climate, IQ Capital, ABN Amro, Invest International, Temasek, Five Seasons Ventures, Aliment Capital, Sucden Ventures, Genoa Ventures, Polaris Partners |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.